Evidence map›Paper›PMID 35866748›Full record

ReviewRNA biology2022

Principles and correction of 5'-splice site selection.

Florian Malard, Cameron D Mackereth, Sébastien Campagne

Open access · goldAbstract readReview
In one paragraph

Review in RNA biology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.

0numbers the graph read from it
0cells of the map it votes in
16citing papers in PubMed
1.5field-weighted citation impact, top 18% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

16 citing papers in PubMed, 19 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Review
  7. Article
  8. Article
  9. Article
  10. Article
  11. Review
  12. Article
  13. RNA therapeutics.RNA biology · 2024
    Article
  14. Development of Engineered-U1 snRNA Therapies: Current Status.International journal of molecular sciences · 2023
    Review
  15. Early Splicing Complexes and Human Disease.International journal of molecular sciences · 2023
    Review
  16. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors at 1 institution in 1 country.

Florian MalardInserm U1212, CNRS UMR5320, ARNA Laboratory, University of Bordeaux, Bordeaux Cedex, France.ORCID 0000-0003-4908-1588
Cameron D MackerethInserm U1212, CNRS UMR5320, ARNA Laboratory, University of Bordeaux, Bordeaux Cedex, France.ORCID 0000-0002-0776-7947
Sébastien CampagneInserm U1212, CNRS UMR5320, ARNA Laboratory, University of Bordeaux, Bordeaux Cedex, France.ORCID 0000-0002-0094-4760
Centre National de la Recherche Scientifique · FR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

In Eukarya, immature mRNA transcripts (pre-mRNA) often contain coding sequences, or exons, interleaved by non-coding sequences, or introns. Introns are removed upon

Indexed as

Ribonucleoprotein, U1 Small NuclearRNA PrecursorsAlternative SplicingRNA, MessengerRNA, Small NuclearRNA Splice SitesRNA SplicingRibonucleoprotein, U1 Small NuclearRNA, MessengerRNA PrecursorsRNA, Small NuclearRNA Splice Sites5’-splice siteantisense oligonucleotidesRNA splicingsplicing modifiersU1 snRNP

Identifiers

PMID35866748
PMCPMC9311317
OpenAlexW4286486123

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.